The Ever-Changing World of Extractables and Leachables, Part 4, A Free Virtual Conference
May 18th 2022Wednesday, May 18th, 2022 at 3pm BST | 10am EDT | 4pm CEST | 7am PDTJoin global industry and regulatory experts as they discuss current E&L hot topics on pharmaceuticals, biopharmaceuticals and medical devices.
Industrializing High-Throughput Glycoproteomics Using AI for Clinical Use
April 26th 2022Aberrant glycosylation of proteins has been implicated in key steps of disease biology, including the hallmarks of cancer as well as inflammation cascades associated with autoimmunity and aging. InterVenn Biosciences harnesses the predictive powers of artificial intelligence combined with cutting edge mass spectrometry to discover clinically relevant biomarkers that can only be revealed by high-resolution analysis of the glycoproteome.
Oligonucleotide Purification and Characterization - Tips for Success
March 30th 2022Wednesday, March 30th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Applying the appropriate tools for oligonucleotide purification and subsequent analysis is a unique challenge requiring application specific solutions. Join Drs. Anne Blackwell and Matthew L. Turner of Agilent Technologies for tips on oligonucleotide analysis and purification with Agilent’s suite of Bio LC solutions.
Glycomics/Glycoproteomics for Biopharmaceutical and Biotechnology Industries
March 16th 2022Wednesday, March 16th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Please join us for a series of three intense investigations into the practicalities required to define, identify, and explore the functions of important biological molecules including glycans, monoclonal antibodies, and oligonucleotides. We outline cutting edge and mainstay analytic tools and protocols, with multiple case studies and practical examples from world leading experts.
The Ever-Changing World of Extractables and Leachables, Part 2 A Free Virtual Conference
February 24th 2021***Live: Wednesday, February 24, 2021 at 10am EST | 3pm GMT | 4pm CET*** Join global industry and regulatory experts as they discuss current E&L hot topics related to pharmaceuticals, biopharmaceuticals and medical devices. ***On demand available after final airing until Feb. 24, 2022***